Takotsubo cardiomyopathy: Healing a broken heart
Not all medical problems are easy to diagnose, and it can be especially tricky when similar symptoms occur in different diseases. It is important…
Oncology
Long-term cancer survivorship nurse practitioner care model promotes patient quality of life
It’s not uncommon for cancer patients to say they classify themselves as a cancer survivor by having lived at least 5 years past the…
Differentiating statistical significance and clinical significance
To implement evidence-based practice, nurses must be able to comprehend and interpret research. That means you need to understand the distinction between statistical significance…
Any nurse can do it: Sustaining change when volunteering overseas
Arriving back in Ethiopia for the third time after having left only four months earlier, I had many questions. Had the Ethiopian nurses managed…
Nursing practice and work environment
According to the Centers for Disease Control and Prevention (CDC), 18% of Americans smoke cigarettes and more than half of these smokers want to…
FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose disease progressed…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine types of…
Letter to the Editor – Creating high performance interprofessional teams
February 15, 2015 Lillee Gelinas, MSN, RN, FAAN Editor-In-Chief American Nurse Today myamericannurse.com Dear Editor, I am writing in response to the article entitled…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Resting not regretting
“We are such stuff as dreams are made on, and our little life is rounded with a sleep.” — William Shakespeare As informal mentors,…
Takotsubo cardiomyopathy: Healing a broken heart
Not all medical problems are easy to diagnose, and it can be especially tricky when similar symptoms occur in different diseases. It…
Long-term cancer survivorship nurse practitioner care model promotes patient quality of life
It’s not uncommon for cancer patients to say they classify themselves as a cancer survivor by having lived at least 5 years…
Differentiating statistical significance and clinical significance
To implement evidence-based practice, nurses must be able to comprehend and interpret research. That means you need to understand the distinction between…
Any nurse can do it: Sustaining change when volunteering overseas
Arriving back in Ethiopia for the third time after having left only four months earlier, I had many questions. Had the Ethiopian…
Nursing practice and work environment
According to the Centers for Disease Control and Prevention (CDC), 18% of Americans smoke cigarettes and more than half of these smokers…
FDA approves new drug for thyroid cancer
On February 13, the U.S. Food and Drug Administration (FDA) approved Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer whose…
New HPV vaccine offers greater protection against cervical cancer
A study in The New England Journal of Medicine Scientists reports that a new HPV (human papilloma virus) vaccine protects against nine…
Letter to the Editor – Creating high performance interprofessional teams
February 15, 2015 Lillee Gelinas, MSN, RN, FAAN Editor-In-Chief American Nurse Today myamericannurse.com Dear Editor, I am writing in response to the…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Resting not regretting
“We are such stuff as dreams are made on, and our little life is rounded with a sleep.” — William Shakespeare As…